Ichiro Horie

17PUBLICATIONS
48CO-AUTHORS
Population trends and policiesGene expression (incl. microarray and other genome-wide approaches)Major global burdens of diseasePredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 30, 2026
Renal function trajectories before and during the COVID-19 pandemic in Japanese individuals with type 1 diabetes: a post-hoc analysis of the multicenter retrospective investigation by the IPRA-CKD study group.

|Sep 23, 2026
Rapid progression of β-cell dysfunction in a patient with glycogen storage disease type 1a complicated by diabetes: longitudinal assessment by serial OGTTs with a review of the literature.

|Nov 26, 2025
Impacts of physical, metabolic, and immunological factors on the exophthalmometry values of a contemporary Japanese population with/without Graves' disease.

Erika Nakaji, Yuta Nakamura, Ichiro Horie

|Sep 15, 2025
Slowly progressive type 1 diabetes and female sex as associated factors for pancreatic abnormalities on diagnostic imaging indicating precancerous potential.

Tomoyasu Fukui, Tetsuro Kobayashi, Takuya Awata

|Sep 03, 2025
Real-world clinical experience of reduced-dose initiation of lenvatinib in Japanese patients with radioiodine-refractory differentiated thyroid cancer.

Yomi Nakashima, Ichiro Horie, Haruka Arimori

|Jun 26, 2025
Adjunct Therapy with Ipragliflozin Exerts Limited Effects on Kidney Protection in Type 1 Diabetes: A Retrospective Study Conducted at 25 Centers in Japan (IPRA-CKD).

Yuta Nakamura, Ichiro Horie, Hiroshi Yano

Pageof 3

Frequent Collaborators

4 joint publications

Yuta Nakamura

3 joint publications

Yoshiki Kusunoki

3 joint publications

Yushi Hirota

3 joint publications

Tomoyasu Fukui